
Azilsartan medoxomil
CAS No. 863031-21-4
Azilsartan medoxomil( TAK 491 | TAK-491 | TAK491 )
Catalog No. M16246 CAS No. 863031-21-4
A specific and potent angiotensin II type 1 receptor (AT1) antagonist with IC50 of 2.6 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 43 | In Stock |
![]() ![]() |
5MG | 72 | In Stock |
![]() ![]() |
10MG | 110 | In Stock |
![]() ![]() |
25MG | 200 | In Stock |
![]() ![]() |
50MG | 335 | In Stock |
![]() ![]() |
100MG | 494 | In Stock |
![]() ![]() |
500MG | 1053 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAzilsartan medoxomil
-
NoteResearch use only, not for human use.
-
Brief DescriptionA specific and potent angiotensin II type 1 receptor (AT1) antagonist with IC50 of 2.6 nM.
-
DescriptionA specific and potent angiotensin II type 1 receptor (AT1) antagonist with IC50 of 2.6 nM, used in the treatment of adults with essential hypertension. Hypertension Approved.
-
In Vitro——
-
In VivoAnimal Model:Rats Dosage:0.03-10 mg/kg Administration:oral gavage, once a day for 4 days Result:Reduced myocardial infarct size.Increased calcium-dependent nitric oxide synthase activity.Increased Akt, ERK 1/2 and eNOS phosphorylation and inhibited BAX activation.
-
SynonymsTAK 491 | TAK-491 | TAK491
-
PathwayGPCR/G Protein
-
TargetAngiotensin Receptor
-
RecptorAT1receptor
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number863031-21-4
-
Formula Weight568.5336
-
Molecular FormulaC30H24N4O8
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)OCC6=C(OC(=O)O6)C
-
Chemical Name1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. French C, et al. J Cardiovasc Pharmacol. 2011 Aug;58(2):143-8.
2. Kusumoto K, et al. Eur J Pharmacol. 2011 Nov 1;669(1-3):84-93.
3. B?nner G, et al. J Hum Hypertens. 2013 Aug;27(8):479-86.
molnova catalog



related products
-
Olmesartan medoxomil
An angiotensin II receptor antagonist which has been used for the treatment of high blood pressure.
-
Norleual
Angiotensin IV analog. Highly potent HGF/c-MET inhibitor (IC50 = 3 pM). Inhibits HGF-induced MDCK cell proliferation and invasion in vitro. Also AT4 receptor antagonist; disrupts LTP stabilization. Antiangiogenic.
-
Azilsartan medoxomil...
An orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM.